对抗Klebsiella Pneumoniae的菌体治疗方法
Weijia Ding1, Yicheng Wen1, Liang Chen2
1Department of Clinical Laboratory, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Microorganisms
|January 28, 2026
概括
抗生素耐药性构成了全球主要的健康威胁. 本综述探讨了菌体 (菌体) 疗法作为一种有希望的替代治疗多药耐药的Klebsiella肺炎感染,讨论当前的进展和挑战.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- 抗生素耐药性,特别是多药耐药性和高毒性Klebsiella pneumoniae的抗生素耐药性,是一个关键的全球健康问题.
- 传统抗生素效率下降,需要探索替代治疗策略.
研究的目的:
- 审查当前关于克莱布西拉肺炎感染的细菌体 (菌体) 治疗的知识.
- 突出基于菌体的治疗方法和克服现有挑战的策略的最新进展.
主要方法:
- 对菌体与宿主相互作用和菌体治疗应用的文献综述.
- 对菌体尾酒,抗生素联合治疗和菌体衍生蛋白对抗K. pneumoniae的最新研究进行分析.
主要成果:
- 菌体对抗多药耐药的K. pneumoniae具有显著的治疗潜力.
- 最近的创新包括菌体尾酒,协同抗生素组合和菌体衍生蛋白质疗法.
结论:
- 菌体疗法代表了抗生素对抗K. pneumoniae感染的有希望的替代方案.
- 进一步的研究和创新对于优化菌体治疗和解决临床应用的剩余挑战至关重要.
相关概念视频
Lysogenic Cycle of Bacteriophages
67.7K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.7K
Lytic Cycle of Bacteriophages
77.7K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.7K
DNA Bacteriophages
959
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
959
Pneumonia I: Introduction
862
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
862
Pneumonia II: Pathophysiology
2.8K
The pathophysiology of pneumonia involves the following steps:
2.8K
Pneumonia IV: Management
807
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
807


